Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Positive Technologies ' net profit for 2024 fell 2.5 times

4/8/25 POSI

VK's additional issue worth ₽115 billion will be purchased by the company's key shareholders

4/8/25 VKCO

Kamaz will import replacement of Bosch and ZF Friedrichshafen components.

4/7/25 KMAZ

Board of Directors of Omsk airport recommended that dividends be paid for 2024

4/7/25 ARPO

Sovcombank completes acquisition of Home Bank

4/7/25 SVCB

In Cuba, the first UAZ trucks came off the assembly line

4/7/25 SVAV

Board of Directors of KuibyshevAzot recommended that dividends be paid for 2024

4/7/25 KAZT

MKB's net profit for 2024 has almost tripled

4/7/25 CBOM

International Trade Center reported for 2024 by IFRS

4/5/25 WTCM

PIK reported for 2024 by RAS

4/4/25 PIKK